Go Deep
Supha Pharmachem Limited
Supha Pharmachem Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 12,335 | 2.1 | 0.23 | 10.34 | 0.27 |
| Sep 2026 | 12,378 | 2.0 | 0.22 | 10.34 | 0.26 |
| Sep 2026 | 12,378 | 2.0 | 0.22 | 10.34 | 0.26 |
| Sep 2026 | 12,378 | 2.0 | 0.22 | 10.34 | 0.26 |
| Sep 2026 | 12,378 | 2.0 | 0.22 | 10.34 | 0.26 |
| Sep 2026 | 12,335 | 2.1 | 0.23 | 10.34 | 0.27 |
| Oct 2026 | 10,572 | 2.0 | 0.22 | 10.34 | 0.26 |
| Oct 2026 | 9,705 | 2.0 | 0.22 | 10.34 | 0.26 |
Supha Pharmachem Limited Quarterly Results
| Line Item | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 1,110,582,000.0 | 1,133,667,000.0 | 2,643,226,000.0 |
| Net Profit | 86,234,000.0 | 46,488,000.0 | -20,460,000.0 |
| EPS | 0.1 | 0.1 | — |
Supha Pharmachem Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | 4,052,511,000.0 | 40,417,067,000.0 | 5,098,366,000.0 | 5,047,919,000.0 |
| Net Profit | 21,294,000.0 | 327,302,000.0 | 54,261,000.0 | 10,778,000.0 |
| EPS | 0.0 | 0.6 | 0.1 | 0.0 |
Supha Pharmachem Limited Balance Sheet
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Total Assets | 17,203,490,000.0 | 19,479,236,000.0 | 11,542,227,000.0 | 2,237,563,000.0 |
| Total Liabilities | 16,764,579,000.0 | 19,049,658,000.0 | 11,438,584,000.0 | 2,188,181,000.0 |
| Total Equity | 438,911,000.0 | 429,578,000.0 | 103,643,000.0 | 49,382,000.0 |
Owes vs Owns
Supha Pharmachem Limited owed ₹0.94 for every ₹1 it owned in Sep 2025, down from ₹0.98 in Mar 2022.
| Period | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.94× | 0.97× | 0.98× | 0.99× | 0.98× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Supha Pharmachem Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2025
Receivables 44.9%Inventory 15.7%Other assets 39.4%
How it's funded — Mar 2025
Short-term debt 2.6%Payables 29.1%Other liabilities 65.7%Shareholders' equity 2.6%
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.8 | 1.5 | 21.9 | 1.4 |
| Receivables | 771.6 | 920.6 | 172.4 | 64.0 |
| Inventory | 269.4 | 133.2 | 7.3 | 83.9 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.1 | 0.1 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 677.5 | 892.5 | 952.6 | 74.3 |
| Liabilities & equity | ||||
| Short-term debt | 44.9 | 57.7 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 501.0 | 712.3 | 84.2 | 124.6 |
| Other liabilities | 1,130.6 | 1,135.0 | 1,059.6 | 94.3 |
| Shareholders' equity | 43.9 | 43.0 | 10.4 | 4.9 |
| Net tangible assets | 43.9 | 43.0 | 10.4 | 4.8 |
Supha Pharmachem Limited Cash Flow
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Operating Activities | -11,443,889,000.0 | -741,611,000.0 | 205,000,000.0 | 112,830,000.0 |
| Investing Activities | 1,289,000.0 | 938,000.0 | -427,000.0 | -498,000.0 |
| Financing Activities | 11,361,045,000.0 | 538,294,000.0 | -373,000.0 | -106,084,000.0 |